Shanghai MicroPort EP MedTech Co., Ltd. (SHA:688351)
24.38
+0.51 (2.14%)
Last updated: Nov 3, 2025, 9:50 AM CST
SHA:688351 Revenue
Shanghai MicroPort EP MedTech had revenue of 112.65M CNY in the quarter ending September 30, 2025, with 21.78% growth. This brings the company's revenue in the last twelve months to 458.70M, up 19.46% year-over-year. In the year 2024, Shanghai MicroPort EP MedTech had annual revenue of 413.17M with 25.51% growth.
Revenue (ttm)
458.70M
Revenue Growth
+19.46%
P/S Ratio
24.83
Revenue / Employee
928.55K
Employees
577
Market Cap
11.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 413.17M | 83.97M | 25.51% |
| Dec 31, 2023 | 329.19M | 68.87M | 26.46% |
| Dec 31, 2022 | 260.32M | 70.30M | 36.99% |
| Dec 31, 2021 | 190.03M | 48.74M | 34.50% |
| Dec 31, 2020 | 141.29M | 23.85M | 20.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |